Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α

References

• ChengZJVapaataloHMervaalaEAngiotensin II and vascular inflammationMed Sci Monit2005116RA194RA20515917731
   PubMed Web of Science ®Google Scholar
• SuzukiYRuiz-OrtegaMGomez-GuerreroCTominoYEgidoJAngiotensin II, the immune system and renal diseases: another road for RAS?Nephrol Dial Transplant20031881423142612897073
   PubMed Web of Science ®Google Scholar
• GageJRFonarowGHamiltonMWidawskiMMartínez-MazaOVredevoeDLBeta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failureNeuroimmunomodulation200411317318015067208
   PubMed Web of Science ®Google Scholar
• RosensonRSModulating atherosclerosis through inhibition or blockade of angiotensinClin Cardiol200326730531112862295
   PubMed Web of Science ®Google Scholar
• RosensonRSNew approaches in the intensive management of cardiovascular risk in the metabolic syndromeCurr Probl Cardiol200530524127915829899
   PubMed Web of Science ®Google Scholar
• SteenVTargeted therapy for systemic sclerosisAutoimmun Rev20065212212416431341
   PubMed Web of Science ®Google Scholar
• ZhangXLiZZLiuDFXuXMeiZCShenWAngiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponec-tin receptor-2 in rats with type 2 diabetesClin Exp Pharmacol Physiol200936763163619076162
   PubMed Web of Science ®Google Scholar
• HagiwaraSIwasakaHMatumotoSHidakaSNoguchiTEffects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro modelsCrit Care Med200937262663319114890
   PubMed Web of Science ®Google Scholar
• FlammerAJSudanoIHermannFAngiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritisCirculation2008117172262226918427133
   PubMed Web of Science ®Google Scholar
• Sanz-RosaDOubiñaMPCedielEEffect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB systemAm J Physiol Heart Circ Physiol20052881H111H11515308481
   PubMed Web of Science ®Google Scholar
• VerhoeckxKCGaspariMBijlsmaSIn search of secreted protein biomarkers for the anti-inflammatory effect of beta2-adrenergic receptor agonists: application of DIGE technology in combination with multivariate and univariate data analysis toolsJ Proteome Res2005462015202316335946
   PubMed Web of Science ®Google Scholar
• IzeboudCAMonshouwerMvan MiertASWitkampRFThe beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivoInflamm Res199948949750210522805
   PubMed Web of Science ®Google Scholar
• AcklandGLYaoSTRudigerACardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in ratsCrit Care Med201038238839419829100
   PubMed Web of Science ®Google Scholar
• FranceschiCCapriMMontiDInflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humansMech Ageing Dev200712819210517116321
   PubMed Web of Science ®Google Scholar
• MoraesCFSouzaERSouzaVCA common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older womenClin Chim Acta20083961–2707518657531
   PubMed Web of Science ®Google Scholar
• IV Brazilian Guidelines in Arterial Hypertension Work GroupsIV Brazilian guidelines in arterial hypertensionArq Bras Cardiol200482Suppl 4722 Portuguese15107944
   PubMedGoogle Scholar
• CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinineNephron197616131411244564
   PubMed Web of Science ®Google Scholar
• FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
   PubMed Web of Science ®Google Scholar
• International Diabetes FederationIDF Global Guideline for Managing Older People with Type 2 Diabetes Available from: http://www.idf.org/sites/default/files/IDF-Guideline-for-older-people-T2D.pdfAccessed December 11, 2014
   Google Scholar
• MionDJrda SilvaGVde GusmãoJLDo Brazilian physicians follow the Brazilian guidelines on hypertension?Arq Bras Cardiol200788221221717384840
   PubMed Web of Science ®Google Scholar
• NóbregaOTFaleirosVPTellesJLGerontology in the developing Brazil: achievements and challenges in public policiesGeriatr Gerontol Int20099213513919740356
   PubMed Web of Science ®Google Scholar
• YuengsrigulAChinTWNussbaumEImmunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cellsAnn Allergy Asthma Immunol1999836 Pt 155956610619350
   PubMed Web of Science ®Google Scholar
• XuBMakrisAThorntonCOgleRHorvathJSHennessyAAnti-hypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancyJ Hypertens200624591592216612254
   PubMed Web of Science ®Google Scholar
• RolfeMWKunkelSLRowensBStandifordTJCragoeEJJrStrieterRMSuppression of human alveolar macrophage-derived cytokines by amilorideAm J Respir Cell Mol Biol1992665765821591007
   PubMed Web of Science ®Google Scholar
• HaddadJJLandSCAmiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epitheliumAm J Respir Cell Mol Biol200226111412611751211
   PubMed Web of Science ®Google Scholar
• HaddadJJAmiloride and the regulation of NF-kappaB: an unsung crosstalk and missing link between fluid dynamics and oxidative stress-related inflammation – controversy or pseudo-controversy?Biochem Biophys Res Commun2005327237338115629126
   PubMed Web of Science ®Google Scholar
• GavrilovaSADemidovLVMedvedevaNAAshmarinIPChronic administration of interferon-a decreases blood pressure and heart rate in ratsBull Exp Biol Med2000129541341610977936
   PubMed Web of Science ®Google Scholar
• ForseyRJThompsonJMErnerudhJPlasma cytokine profiles in elderly humansMech Ageing Dev2003124448749312714257
   PubMed Web of Science ®Google Scholar
• MaggioMGuralnikJMLongoDLFerrucciLInterleukin-6 in aging and chronic disease: a magnificent pathwayJ Gerontol A Biol Sci Med Sci200661657558416799139
   PubMed Web of Science ®Google Scholar
• DelvesPJRoittIMThe immune system. Second of two partsN Engl J Med2000343210811710891520
   PubMed Web of Science ®Google Scholar
• RoubenoffRHarrisTBAbadLWWilsonPWDallalGEDinarelloCAMonocyte cytokine production in an elderly population: effect of age and inflammationJ Gerontol A Biol Sci Med Sci1998531M20M269467429
   PubMed Web of Science ®Google Scholar
• KrabbeKSPedersenMBruunsgaardHInflammatory mediators in the elderlyExp Gerontol200439568769915130663
   PubMed Web of Science ®Google Scholar
• StarkieROstrowskiSRJauffredSFebbraioMPedersenBKExercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humansFASEB J200317888488612626436
   PubMed Web of Science ®Google Scholar
• PetersenAMPedersenBKThe anti-inflammatory effect of exerciseJ Appl Physiol (1985)20059841154116215772055
   PubMed Web of Science ®Google Scholar
• BruunsgaardHPedersenANSchrollMSkinhojPPedersenBKImpaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humansClin Exp Immunol1999118223524110540184
   PubMed Web of Science ®Google Scholar
• BonafèMOlivieriFCavalloneLA gender – dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevityEur J Immunol20013182357236111500818
   PubMed Web of Science ®Google Scholar
• KarnikowskiMCórdovaCOliveiraRJKarnikowskiMGNóbrega OdeTNon-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adultsSao Paulo Med J2007125633333718317603
   PubMed Web of Science ®Google Scholar
• EpsteinBJSmithSMChoksiRRecent changes in the landscape of combination RAS blockadeExpert Rev Cardiovasc Ther20097111373138419900020
   PubMedGoogle Scholar
• JATOS Study GroupPrincipal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)Hypertens Res200831122115212719139601
   PubMed Web of Science ®Google Scholar
• SarutaTHayashiKOgiharaTNakaoKFukuiTFukiyamaKCASE-J Study GroupEffects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J StudyHypertens Res200932650551219390535
   PubMed Web of Science ®Google Scholar
• OgiharaTFujimotoANakaoKSarutaTCASE-J Trial GroupARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trialExpert Rev Cardiovasc Ther2008691195120118939907
   PubMedGoogle Scholar